Intravascular Red Light Therapy after Coronary Stenting Ñ Angiographic and Clinical Follow-up Study in Humans

Area of Science:

• Cardiovascular Medicine
• Biomedical Engineering
• Interventional Cardiology

Background:

• Coronary restenosis remains a significant complication after coronary artery stenting.
• Intravascular red light therapy (IRLT) has shown efficacy in animal models for reducing neointimal hyperplasia.
• Catheter-based IRLT offers a potential therapeutic approach for preventing post-stenting restenosis.

Purpose of the Study:

• To evaluate the safety and efficacy of catheter-based intravascular red light therapy (IRLT) in preventing restenosis after coronary stenting.
• To assess key angiographic and clinical outcomes in patients undergoing IRLT post-stenting.

Main Methods:

• A prospective study involving 22 patients with angina pectoris undergoing coronary stenting.
• Catheter-based IRLT was performed using a 650 nm diode laser at 10 megawatts via a rapid exchange balloon system.
• Safety and efficacy were assessed through procedural success, complication monitoring, and angiographic/clinical follow-up.

Main Results:

• The IRLT procedure was successful in all patients with no procedural or in-hospital complications.
• At 6-month follow-up, the mean minimal lumen diameter was 2.57 mm, with a late lumen loss of 0.49 mm.
• Four patients (18%) developed angiographic restenosis; 2 required repeat angioplasty, resulting in 91% event-free survival at 10.9 months.

Conclusions:

• Catheter-based intravascular red light therapy (IRLT) is a safe and feasible adjunctive treatment following coronary artery stenting.
• IRLT is associated with promisingly low rates of angiographic restenosis and favorable clinical outcomes.
• Further investigation with larger cohorts is warranted to confirm the long-term efficacy of IRLT in preventing coronary restenosis.